投資評等
最後更新日期：2025/1/9
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/12/17 | Pivotal Research Group | Hold >> Buy | 610 |
| 2010/12/13 | Wedbush | Neutral >> Outperform | $575 >> $750 |
| 2010/10/15 | Caris & Company | Average >> Buy | $550 >> $700 |
| 2010/10/12 | Wedbush | Underperform >> Neutral | $525 >> $575 |
| 2010/5/21 | MKM Partners | Neutral >> Buy | 600 |
| 2009/10/16 | Benchmark | Hold >> Buy | |
| 2009/8/25 | ThinkEquity | Source of Funds >> Buy | $400 >> $550 |
| 2009/3/31 | Merriman Curhan Ford | Neutral Buy | |
| 2009/3/26 | Canaccord Adams | Hold Buy | $300 $400 |
| 2006/2/6 | Stifel Nicolaus | Sell Hold | 400 |
| 2005/4/20 | RBC Capital Mkts | Sector Perform->Outperform | 230 |
| 2005/4/5 | Lehman Brothers | Equal-weight->Overweight | |
| 2005/3/8 | UBS | Reduce->Neutral | |
| 2005/2/18 | Pacific Growth Equities | Equal Weight->Over Weight | |
| 2005/2/14 | CIBC Wrld Mkts | Sector Perform->Sector Outperform | |
| 2005/2/2 | Jefferies Co | Hold->Buy | 230 |
| 2004/12/21 | Caris Company | Above Average->Buy | |
| 2004/11/29 | AmTech Research | Hold->Buy | 210 |
| 2004/10/22 | AmTech Research | Sell->Hold | 180 |
| 2004/9/20 | Caris->Company | Average->Above Average | |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2011/10/5 | Stifel Nicolaus | Buy >> Hold | |
| 2010/1/22 | Collins Stewart | Buy >> Hold | $635 >> $615 |
| 2009/6/8 | Benchmark | Buy >> Hold | |
| 2009/3/19 | AmTech Research | Buy Neutral | |
| 2006/4/12 | JMP Securities | Strong Buy Mkt Outperform | |
| 2005/11/29 | Stanford Research | Buy->Hold | |
| 2005/7/22 | Needham Co | Buy->Hold | 250 |
| 2005/3/14 | Caris Company | Above Average->Average | |
| 2005/2/24 | RBC Capital Mkts | Top Pick->Sector Perform | 250 |
| 2005/2/22 | Caris Company | Buy->Above Average | |
| 2004/10/11 | AmTech Research | Hold->Sell | |
| 2004/10/4 | Jefferies Co | Buy->Hold | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2011/8/15 | Hilliard Lyons | Buy | 700 |
| 2011/6/1 | Barclays Capital | Overweight | |
| 2011/1/19 | ISI Group | Hold | 675 |
| 2011/1/5 | Canaccord Genuity | Buy | 750 |
| 2010/8/17 | Wedbush | Underperform | 525 |
| 2009/7/30 | UBS | Buy | 525 |
| 2009/4/14 | Benchmark | Buy | 430 |
| 2008/11/21 | Merriman Curhan Ford | Sell | |
| 2007/3/28 | Nollenberger Capital | Buy | 575 |
| 2007/3/28 | AG Edwards | Buy | 550 |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 2015/10/20 | Wedbush | Neutral | 700 |
| 2011/7/15 | Needham | Buy | 725 |
| 2010/7/9 | Kaufman Bros | Buy | 640 |
| 2010/1/28 | Thomas Weisel | Overweight | $675 >> $690 |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2014/4/17 | Deutsche Bank | Buy | $665 >> $625 |
| 2013/10/18 | Deutsche Bank | Buy | $970 >> $1220 |
| 2013/7/19 | UBS | Buy | $945 >> $1020 |
| 2013/7/9 | Deutsche Bank | Buy | $930 >> $1010 |
| 2013/4/19 | Barclays | Overweight | $850 >> $875 |
| 2012/9/27 | Argus | Buy | $730 >> $875 |
| 2012/9/26 | Canaccord Genuity | Buy | $700 >> $850 |
| 2012/7/20 | The Benchmark Company | Hold | $615 >> $625 |
| 2012/7/17 | Oppenheimer | Outperform | $733 >> $752 |
| 2012/6/20 | The Benchmark Company | Hold | $650 >> $615 |